Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.3%

2 terminated out of 32 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

31%

10 trials in Phase 3/4

Results Transparency

23%

5 of 22 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (13)
P 2 (1)
P 3 (5)
P 4 (5)

Trial Status

Completed22
Unknown6
Recruiting2
Terminated2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT02290834Not ApplicableRecruitingPrimary

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

NCT04556227Not ApplicableRecruiting

Simultaneous Recumbent Cycling and Cognitive Training

NCT02920632Not ApplicableCompleted

Cognitive Training in Parkinson Study

NCT02551952Not ApplicableCompleted

Digital Game: A Scale to Evaluate the Perioperative Cognitive Function

NCT03504501Phase 2Terminated

Synaptic Plasticity and Cognitive Function in RASopathies

NCT02044887Not ApplicableCompletedPrimary

Physical Activity to Patients With Dementia and Their Caregivers.

NCT03095170Not ApplicableTerminated

Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

NCT04006756Not ApplicableCompleted

A Study on Better Cognitive Functioning Through Braintraining on the Internet

NCT01739933Phase 3Completed

The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure

NCT02182817Unknown

Exposure to General Anaesthesia in Infancy and Neurocognitive Development

NCT04557592Completed

Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYs

NCT02936401Not ApplicableCompletedPrimary

Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders

NCT01211522Phase 3Completed

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

NCT01367236Phase 4Completed

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

NCT02536976Phase 4Completed

Mirabegron in Parkinson Disease and Impaired Cognition

NCT03064308Not ApplicableCompletedPrimary

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

NCT02265757Not ApplicableCompleted

Behavioral Interventions to Prevent or Delay Dementia

NCT02042001Phase 4CompletedPrimary

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

NCT02723318Not ApplicableCompletedPrimary

The Impact of Family Financial Support on Cognition

NCT01713491Completed

Pre-stroke Cognitive Status and Thrombolytic Therapy

Scroll to load more

Research Network

Activity Timeline